Get started
Author

Ramesh Babu Pothineni

Observed names: Dr. Ramesh Babu Pothineni, Potineni, Ramesh Babu, R B Pothineni, R. B. Pothineni, Ramesh B Pothineni, Ramesh B Potineni, Ramesh B. Pothineni, Ramesh Babu Potineni, Ramesh Pothineni, Rameshbabu Pothineni
ORCID: 0000-0001-6983-0828
Observed ORCID: 0000-0001-6983-0828
OpenAlex ID: A5114036122
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
2019 · Kausik K Ray, Helen M Colhoun, et al. · The Lancet Diabetes & Endocrinology · 325
PDF
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
2021 · Gregory G. Schwartz, Michael Szarek, et al. · Journal of the American College of Cardiology · 157
PDF
Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome
2021 · Gorav Batra, Tatevik Ghukasyan Lakic, et al. · JAMA Cardiology · 131
PDF
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
2022 · Emil Hagström, P. Gabriel Steg, et al. · Circulation · 121
PDF
Dual left anterior descending coronary artery: surgical revascularization in 4 patients.
2000 · L R Sajja, A Farooqi, et al. · PubMed Central · 54
PDF
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
2021 · Gregory G. Schwartz, Michael Szarek, et al. · Diabetes Care · 40
PDF
Lymphocyte subsets in acute rheumatic fever and rheumatic heart disease
1989 · R. Bhatia, J. Narula, et al. · Clinical Cardiology · 34
Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES
2025 · P. Gabriel Steg, Michael Szarek, et al. · Circulation · 29
PDF
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
2024 · Shaun G Goodman, Philippe Gabriel Steg, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 27
PDF
New atherogenic indices: Assessment of cardio vascular risk in post menopausal dyslipidemia
2015 · Pusapati Madan Ranjit, Girija Sankar Guntuku, et al. · Asian Journal of Medical Sciences · 25
PDF
Immunologic and immunogenetic studies in rheumatic fever and rheumatic heart disease
1990 · K. S. Reddy, Jagat Narula, et al. · The Indian Journal of Pediatrics · 18
Clinical outcomes of ultrathin biodegradable polymer-coated sirolimus-eluting stents in an all-comer population: One-year results from the T-FLEX registry including high-risk subgroups
2021 · Ramesh Babu Pothineni, Andhra Pradesh–India, et al. · The Anatolian Journal of Cardiology · 12
Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease
2025 · Stephen J. Nicholls, Donna H. Ryan, et al. · JAMA Cardiology · 8
Real-World Use Of Ultrathin-Strut Biodegradable Polymer–Coated Sirolimus-Eluting Stents In Patients With Coronary Artery Disease: 6-Month Clinical Outcomes
2019 · Prakash Ajmera, Ramesh Pothineni, et al. · Vascular Health and Risk Management · 6
PDF
Twelve months clinical outcomes of ultrathin strut sirolimus-eluting stent in real-world Indian patients with coronary artery disease.
2022 · Prakash Ajmera, Ramesh Pothineni, et al. · PubMed Central · 5
Comparison of lipid profile and new atherogenic indices among the coronary artery disease (CAD)-negative and -positive diabetic dyslipidemia subjects
2015 · Pusapati Ranjit, Girijasankar Guntuku, et al. · International Journal of Medical Science and Public Health · 5
Retrograde Coronary Sinus Perfusion for Severe Left Main Stenosis
2000 · Lokeswara Rao Sajja, Afroz Farooqi, et al. · Asian Cardiovascular and Thoracic Annals · 4
Tele-Intensive Care Unit-associated Early Recognition of In-hospital Hemodynamic Events and Clinical Outcomes: A Multicenter Observational Study
2026 · Moturu Dharanindra, Ramesh B Potineni, et al. · Indian Journal of Critical Care Medicine · 3
PDF
Ultrathin Strut Biodegradable Polymer-Coated Sirolimus-Eluting Coronary Stents: Patient-Level Pooled Analysis From Two Indian Registries
2023 · Ramesh Babu Pothineni, Prakash Ajmera, et al. · Cureus · 3
PDF
Association of Lipid Profile, Atherogenic Indices, and LPL Hind-III Gene Polymorphism with Coronary Artery Disease Positive Subjects
2017 · Pusapati Madan Ranjit, Girijasankar Guntuku, et al. · International Journal of Pharmaceutical and Clinical Research · 3
Spontaneous Dissection of Left Main Coronary Artery: Surgical Management
2000 · Lokeswara Rao Sajja, Afroz Farooqi, et al. · Asian Cardiovascular and Thoracic Annals · 3
Echo-Doppler assessment of cardiac status in conjoined (thoraco-omphalopagus) twins
1990 · Vishva Dev, Ramesh Babu Pothineni, et al. · Pediatric Cardiology · 3
Efficacy and Safety of Semaglutide According to Frailty Status
2026 · John W. Ostrominski, Jorge Plutzky, et al. · JAMA Cardiology · 2
One-Year Outcomes of Biodegradable Polymer-Coated Sirolimus-Eluting Coronary Stent in Acute Coronary Syndrome: A Patient-Level Pooled Analysis from Two Indian Registries
2024 · Ramesh Babu Pothineni, Prakash Ajmera, et al. · Cardiology · 2
PDF
Observational study of hemodynamic events during interfacility transit of critically ill patients in a 5G tele-ambulance connected to Tele-ICU
2025 · Dharanindra Moturu, Ramesh Babu Potineni, et al. · The Egyptian Journal of Critical Care Medicine · 1
PDF
Works count: 48
Citation count: 1,024
H-index: 12
I10-index: 12
Year
Topic
Type